Bournvita maker Mondelez India, direct-selling giant Amway, and several other packaged food companies have dropped or modified health and nutrition claims on their products following action by India's Food Safety and Standards Authority of India, according to reports on August 25, 2026. The development marks a continuation of the regulator's increasingly assertive stance toward marketing claims made by consumer food and beverage companies operating in the Indian market.
The affected products span health drinks, nutritional supplements and functional food categories, areas that have historically relied heavily on claims around immunity support, growth benefits, and nutritional superiority to differentiate products within India's crowded packaged food and beverage market. FSSAI's action follows a broader pattern of regulatory scrutiny that has intensified over recent years, as authorities have moved to ensure that consumer-facing health and nutrition claims are substantiated by scientific evidence rather than serving primarily as marketing tools.
For Mondelez India, the modification of claims associated with Bournvita follows earlier controversy surrounding the health drink brand, which has faced public and regulatory scrutiny over sugar content and marketing practices in previous years. The latest action suggests that regulatory pressure on the health-drink category has continued to build, with companies increasingly required to recalibrate both product formulations and marketing language to align with evolving standards around what constitutes a defensible health claim.
Amway's inclusion in the regulatory action is notable given the company's business model, which relies heavily on direct sellers making health and wellness claims to consumers as part of the sales process — a structure that can make consistent compliance with evolving regulatory standards more operationally complex than for companies selling through conventional retail channels, where marketing messaging is more centrally controlled.
The broader implications of FSSAI's action extend beyond the specific companies named, serving as a signal to India's wider packaged food and nutraceuticals industry that health and nutrition claims will face closer scrutiny going forward. This comes at a time when consumer interest in health-oriented food and beverage products has been rising rapidly, creating strong commercial incentives for companies to make bold claims about their products' benefits — incentives that regulators appear increasingly focused on tempering with evidentiary requirements.
The regulatory tightening also intersects with broader food safety enforcement activity in India this week, with Karnataka authorities separately suspending the food licences of quick-commerce platforms Amazon, Instamart and BigBasket over compliance lapses. Taken together, these developments point to a food safety and consumer protection environment in India that is becoming more assertive across the value chain, from the formulation and marketing claims of packaged food manufacturers to the operational compliance of the platforms that deliver those products to consumers.
For companies operating in India's health and nutrition space, the message from regulators appears increasingly clear: claims made to consumers must be backed by robust scientific substantiation, and the era of loosely regulated health marketing in the country's fast-growing functional food and beverage category is giving way to a more rigorous compliance regime that will likely require sustained investment in regulatory affairs and product science going forward.
